Status not kept up to date
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate
NCT05766163 · Azienda Ospedaliera Universitaria Integrata Verona · Updated 12 April 2023
- What is being tested
- DaVinci RARP; Hugo RARP; Versius RARP
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 90 years. About 150 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 14 March 2023, ends Sept 2024. Registered 13 March 2023.
- Results
- None posted yet.
In the researchers' words
The object of this exploratory clinical trial is to evaluate post-operative complications in a population that underwent Robotic Assisted Radical Prostatectomy (RARP) made with multiple platforms: * DaVinci; * Hugo; * Versius. The questions it aims to answer are: * Does the estimation of the post-operative complications suggest something? * Are differences (intra-operative, post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to fill out questionnaires and join one of these three groups: 1. surgery with the daVinci platform; 2. surgery with the Hugo platform; 3. surgery with the Versius platform.
Sites
- Urology Unit, AOUI VeronaVerona, Italy